Publications by authors named "Sudarshan Hebbar"

Claim this Profile
B
Bench to Bedside: Translating Discoveries to Clinical Care in Kidney Disease.
Katharine Epler, Dana Y Fuhrman, Sudarshan Hebbar, Volker Vallon, Mark Hepokoski

Nephron· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction.
Anaïs Saint-Martin Willer, Grégoire Ruffenach, Bastien Masson, Kristelle El Jekmek, Angèle Boët, Sudarshan Hebbar

JCI Insight· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Calcium Release-Activated Calcium Channels to Treat Acute Kidney Injury: Design and Rationale of the KOURAGE Study a Randomized Trial.
Lakhmir S Chawla, Patrick T Murray, Stuart L Goldstein, Andrew Cunningham, Sudarshan Hebbar

Am J Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orai1 calcium channel inhibition prevents progression of chronic pancreatitis.
Viktória Szabó, Noémi Csákány-Papp, Marietta Görög, Tamara Madácsy, Árpád Varga, Sudarshan Hebbar

JCI Insight· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial.
Charles Bruen, Mukhtar Al-Saadi, Edward A Michelson, Maged Tanios, Raul Mendoza-Ayala, Sudarshan Hebbar

Crit Care· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome: Clinical Development of a Calcium Release-Activated Calcium Channel Inhibitor.
Charles Bruen, Joseph Miller, John Wilburn, Caleb Mackey, Thomas L Bollen, Sudarshan Hebbar

Pancreas· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation and validation of the ED-SAS score for very early prediction of mortality and morbidity with acute pancreatitis: a retrospective observational study.
Joseph Miller, Yiyang Wu, Rawan Safa, Georgiana Marusca, Sandeep Bhatti, Sudarshan Hebbar

BMC Emerg Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial.
Joseph Miller, Charles Bruen, Michael Schnaus, Jeffrey Zhang, Sadia Ali, Sudarshan Hebbar

Crit Care· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microglial Calcium Release-Activated Calcium Channel Inhibition Improves Outcome from Experimental Traumatic Brain Injury and Microglia-Induced Neuronal Death.
Atsushi Mizuma, Jong Youl Kim, Rachid Kacimi, Ken Stauderman, Michael Dunn, Sudarshan Hebbar

J Neurotrauma· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings.
Sarikapan Wilailak, Karen K L Chan, Chi An Chen, Joo Hyun Nam, Kazunori Ochiai, Sudarshan Hebbar

J Gynecol Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
Karen K L Chan, Chi-An Chen, Joo-Hyun Nam, Kazunori Ochiai, Sarikapan Wilailak, Sudarshan Hebbar

Gynecol Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis.
David G Warnock, Sudarshan Hebbar, Joanne Bargman, John Burkart, Simon Davies

Contrib Nephrol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bardoxolone methyl decreases megalin and activates nrf2 in the kidney.
Scott A Reisman, Glenn M Chertow, Sudarshan Hebbar, Nosratola D Vaziri, Keith W Ward

J Am Soc Nephrol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.
Thomas L Nickolas, Kai M Schmidt-Ott, Pietro Canetta, Catherine Forster, Eugenia Singer, Sudarshan Hebbar

J Am Coll Cardiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse drug reaction driven immunosuppressive drug manipulations: a single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetil.
Karen L Hardinger, Sudarshan Hebbar, Terry Bloomer, Daniel Murillo

Clin Transplant· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider.
Harold J Manley, Cory G Garvin, Debra K Drayer, Gerald M Reid, Walter L Bender, Sudarshan Hebbar

Nephrol Dial Transplant· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with medication-related problems in ambulatory hemodialysis patients.
Harold J Manley, Marcy L McClaran, Debra K Overbay, Marcia A Wright, Gerald M Reid, Sudarshan Hebbar

Am J Kidney Dis· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis